Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
2.
PLoS Negl Trop Dis ; 17(3): e0011150, 2023 03.
Article in English | MEDLINE | ID: mdl-36888575

ABSTRACT

Leishmaniasis is a parasitic disease caused by over 20 species of Leishmania. Transmission is mainly via sandfly bites infected with promastigotes, through the placenta from mother to child, by sexual intercourse, blood transfusion, and occupationally acquired by direct inoculation into the skin. Clinical manifestations vary from self-limited cutaneous disease to a life-threatening visceral infection. In November 2021, a 29-year-old otherwise healthy dermatology resident suffered an accidental needlestick injury while performing a biopsy on a patient with a presumptive diagnosis of an infectious dermatosis, later confirmed as mucocutaneous leishmaniasis caused by Leishmania panamensis. Later, the resident developed an erythematous, painless papule at the point of inoculation, with a central ulcer and painful enlargement of ipsilateral lymph nodes. Biopsy was compatible with leishmaniasis. After completing a 20-day treatment with meglumine antimoniate, the ulcer had healed completely. At the 6-month follow-up, both patients remain asymptomatic. This case serves as a reminder that health providers should have the proper training and knowledge of their hospital management protocol for occupational injuries. Moreover, physicians should bear in mind that leishmaniasis is not exclusively transmitted by sandfly vectors.


Subject(s)
Antiprotozoal Agents , Leishmania , Leishmaniasis, Cutaneous , Leishmaniasis, Visceral , Leishmaniasis , Needlestick Injuries , Child , Pregnancy , Humans , Female , Adult , Needlestick Injuries/complications , Needlestick Injuries/drug therapy , Ulcer/drug therapy , Infectious Disease Transmission, Vertical , Leishmaniasis, Cutaneous/diagnosis , Leishmaniasis, Cutaneous/drug therapy , Leishmaniasis, Cutaneous/parasitology , Antiprotozoal Agents/therapeutic use , Leishmaniasis, Visceral/diagnosis
3.
Am J Clin Dermatol ; 22(3): 367-378, 2021 May.
Article in English | MEDLINE | ID: mdl-33683567

ABSTRACT

Erythema nodosum is the most common form of panniculitis and is characterized by tender erythematous nodules mainly in the lower limbs on the pretibial area. The exact cause of erythema nodosum is unknown, although it appears to be a hypersensitivity response to a variety of antigenic stimuli. Although the etiology is mostly idiopathic, ruling out an underlying disease is imperative before diagnosing primary erythema nodosum. Erythema nodosum can be the first sign of a systemic disease that is triggered by a large group of processes, such as infections, inflammatory diseases, neoplasia, and/or drugs. The most common identifiable causes are streptococcal infections, primary tuberculosis, sarcoidosis, Behçet disease, inflammatory bowel disease, drugs, and pregnancy. We propose a diagnostic algorithm to optimize the initial work-up, hence initiating prompt and accurate management of the underlying disease. The algorithm includes an initial assessment of core symptoms, diagnostic work-up, differential diagnosis, and recommended therapies. Several treatment options for the erythema nodosum lesions have been previously reported; nevertheless, these options treat the symptoms, but not the triggering cause. Making an accurate diagnosis will allow the physician to treat the underlying cause and determine an optimal therapeutic strategy.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Erythema Nodosum/diagnosis , Skin/immunology , Diagnosis, Differential , Drug Therapy, Combination/methods , Erythema Nodosum/drug therapy , Erythema Nodosum/epidemiology , Erythema Nodosum/immunology , Humans , Incidence , Skin/pathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL